09/09/2026 09:00
Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities

Chiesi Group ("Chiesi"), an international research-focused biopharmaceutical company and certified B Corp, today announced its financial results for the six months ended 30 June 2026 ("H1 2026"). Performance across therapeutic areas and regions Chiesi reported revenues of €1.89 billion, representing growth of +3.6% at constant exchange rates (CER) compared with H1 2025. These results do not include the impact of the recent acquisition of KalVista Pharmaceuticals. The Group's growth is suppo...

09/17/2026 09:43
ABZ Innovation Opens One of Europe's Largest Civilian Drone Manufacturing Facilities

ABZ Innovation, a European developer and manufacturer of heavy-duty civilian drones for agricultural and industrial use, today officially opened its new manufacturing facility in Szentendre, Hungary — one of the largest dedicated civilian drone production sites in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917072041/en/ABZ Innovation's new manufacturing facility in Hungary — one of the largest dedicated civilian drone...